Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study

被引:16
作者
Kim, Hyung-Jun [1 ]
Lee, Jong Hyuk [2 ]
Yoon, Soon Ho [2 ]
Kim, Sung A. [1 ]
Kim, Myoung Sil [1 ]
Choi, Sun Mi [1 ]
Lee, Jinwoo [1 ]
Lee, Chang-Noon [1 ]
Han, Sung Koo [1 ]
Yim, Jae-Joon [1 ]
机构
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea
关键词
Clinical medicine; Cohort studies; Diagnosis; Nontuberculous mycobacteria; Progression; LUNG-DISEASE; INDUCED SPUTUM; EPIDEMIOLOGY; AVIUM; ABSCESSUS; IDENTIFICATION; TUBERCULOSIS; PROGRESSION;
D O I
10.1186/s12879-019-4078-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundMicrobiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types.MethodsWe analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens.ResultsThree hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George's Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion.ConclusionsAlthough some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Management of nontuberculous mycobacterial pulmonary disease
    Adelman, Mark H.
    Addrizzo-Harris, Doreen J.
    CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (03) : 212 - 219
  • [22] Profiling mycobacterial communities in pulmonary nontuberculous mycobacterial disease
    Cowman, Steven A.
    James, Phillip
    Wilson, Robert
    Cookson, William O. C.
    Moffatt, Miriam F.
    Loebinger, Michael R.
    PLOS ONE, 2018, 13 (12):
  • [23] Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease
    Lin, Wen-Hong
    Tang, Fei
    Liu, Sheng-Sheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 4208 - 4215
  • [24] Rheumatoid arthritis with nontuberculous mycobacterial pulmonary disease: a retrospective, single-centre cohort study
    Takei, Hiroshi
    Nishina, Naoshi
    Namkoong, Ho
    Suzuki, Katsuya
    Uwamino, Yoshifumi
    Hasegawa, Naoki
    Takeuchi, Tsutomu
    MODERN RHEUMATOLOGY, 2022, 32 (03) : 534 - 540
  • [25] Clinical Implications of Size of Cavities in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Single-Center Cohort Study
    Kang, Hye-Rin
    Hwang, Eui Jin
    Kim, Sung A.
    Choi, Sun Mi
    Lee, Jinwoo
    Lee, Chang-Hoon
    Yim, Jae-Joon
    Kwak, Nakwon
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (03):
  • [26] miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease
    Han, Sun Ae
    Jhun, Byung Woo
    Kim, Su-Young
    Moon, Seong Mi
    Yang, Bumhee
    Kwon, O. Jung
    Daley, Charles L.
    Shin, Sung Jae
    Koh, Won-Jung
    SCIENTIFIC REPORTS, 2020, 10 (01) : 3178
  • [27] A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease
    Winthrop, Kevin
    Rivera, Andrea
    Engelmann, Flora
    Rose, Sasha
    Lewis, Anne
    Ku, Jennifer
    Bermudez, Luiz
    Messaoudi, Ilhem
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2016, 54 (02) : 170 - 176
  • [28] Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease
    Kim, Joong-Yub
    Park, Samina
    Park, In Kyu
    Kang, Chang Hyun
    Kim, Young Tae
    Koh, Jaemoon
    Yim, Jae-Joon
    Kwak, Nakwon
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [29] The Association between Behavioral Risk Factors and Nontuberculous Mycobacterial Pulmonary Disease
    Park, Youngmok
    Kwak, Se Hyun
    Yong, Seung Hyun
    Lee, Su Hwan
    Leem, Ah Young
    Kim, Song Yee
    Lee, Sang Hoon
    Chung, Kyungsoo
    Kim, Eun Young
    Jung, Ji Ye
    Park, Moo Suk
    Kim, Young Sam
    Chang, Joon
    Kang, Young Ae
    YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 702 - 707
  • [30] Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study
    Drysdale, Myriam
    Choate, Radmila
    Brunton, Amanda E.
    Tiberi, Simon
    Gillespie, Iain A.
    Lininger, Noah
    Shrimpton, Susan B.
    Metersky, Mark
    Lapinel, Nicole C.
    McShane, Pamela J.
    Richards, Christopher J.
    Swenson, Colin
    Sharma, Hema
    Mannino, David
    Bronchiectasis Investigator
    NTM Res Registry Investigator
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 83